ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 143.77 USD 0.88%
Market Cap: 3.5B USD

ICU Medical Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ICU Medical Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Operating Income
$130.7m
CAGR 3-Years
36%
CAGR 5-Years
1%
CAGR 10-Years
6%
Haemonetics Corp
NYSE:HAE
Operating Income
$253.8m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
17%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Operating Income
$271m
CAGR 3-Years
-15%
CAGR 5-Years
4%
CAGR 10-Years
-5%
Align Technology Inc
NASDAQ:ALGN
Operating Income
$646.2m
CAGR 3-Years
-5%
CAGR 5-Years
15%
CAGR 10-Years
14%
Lantheus Holdings Inc
NASDAQ:LNTH
Operating Income
$345.4m
CAGR 3-Years
26%
CAGR 5-Years
67%
CAGR 10-Years
24%
Merit Medical Systems Inc
NASDAQ:MMSI
Operating Income
$167.1m
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
14%
No Stocks Found

ICU Medical Inc
Glance View

Market Cap
3.5B USD
Industry
Health Care

ICU Medical Inc. emerged as an intriguing player in the healthcare sector, focusing on a mission-critical niche within the industry—safety and efficiency in medical devices for infusion therapy, oncology, and critical care applications. Founded with an innovative spirit, the company carved out a reputation by addressing a key challenge in the medical field: preventing bloodstream infections and the exposure of healthcare professionals to hazardous substances. This focus led to the development of specialized devices such as needle-free connectors and closed system transfer devices, which are integral to minimizing contamination risks. These innovations not only improved patient outcomes but also enhanced the working conditions of medical professionals, underpinning ICU Medical’s growth trajectory. ICU Medical generates revenue by designing and manufacturing these life-saving devices, which are distributed across hospitals and healthcare facilities worldwide. The company's business model revolves around creating products that align with strict regulatory standards, ensuring both safety and superiority in healthcare settings. As they ventured into diverse product lines, such as infusion pumps and systems, the firm leveraged strategic acquisitions to expand market reach and technological capabilities. These initiatives underscored ICU Medical's commitment to operational synergy and product innovation, enabling the company to remain competitive and continue scaling its operations in a constantly evolving healthcare landscape. With a steady focus on both organic growth and strategic partnerships, ICU Medical remains a crucial player in the global health economy, dedicated to advancing patient care and the efficiency of healthcare delivery systems.

ICUI Intrinsic Value
HIDDEN
Show

See Also

What is ICU Medical Inc's Operating Income?
Operating Income
130.7m USD

Based on the financial report for Sep 30, 2025, ICU Medical Inc's Operating Income amounts to 130.7m USD.

What is ICU Medical Inc's Operating Income growth rate?
Operating Income CAGR 10Y
6%

Over the last year, the Operating Income growth was 143%. The average annual Operating Income growth rates for ICU Medical Inc have been 36% over the past three years , 1% over the past five years , and 6% over the past ten years .

Back to Top